James Patrick Tursi
CIK 1527710 · Executive VP, Global R&D · last filed 2026-06-08
James Patrick Tursi is an Executive VP, Global R&D who has filed 38 SEC Form 4 insider transactions across 7 companies since 2011. The most recent filing, for NRBO, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
7
38
-$2.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Director | 20,568 | $2.36 | $48.5K | $0 | 4 | 2026-06-08 |
| Endo International plc (ENDP) Delisted | Executive VP, Global R&D | 0 | $0.29 | $0 | $0 | 1 | 2022-08-17 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 2,066 | $1.51 | $3.1K | $0 | 9 | 2022-06-10 |
| ANTARES PHARMA, INC. (ATRS) Delisted | EVP, Chief Medical Officer | 45,205 | $5.59 | $252.7K | $0 | 2 | 2019-06-14 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Medical Officer | 242,052 | — | — | $24.6K | 10 | 2018-05-16 |
| POZEN INC /NC (POZN) Delisted | Chief Medical Officer | 30,637 | — | — | $0 | 1 | 2015-12-30 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Chief Medical Officer | 0 | — | — | -$2.95M | 11 | 2015-01-30 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +17,186 | $0 | EDGAR |
| 2025-07-01 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +28,147 | $0 | EDGAR |
| 2024-06-07 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +5,051 | $0 | EDGAR |
| 2023-12-04 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +32,157 | $0 | EDGAR |
| 2022-08-17 | Endo International plc (ENDP) Delisted | Disp (D) | −280,373 | $0 | EDGAR |
| 2022-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +670 | $0 | EDGAR |
| 2021-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +24,510 | $0 | EDGAR |
| 2020-06-11 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +13,393 | $0 | EDGAR |
| 2019-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +45,205 | $132.0K | EDGAR |
| 2019-06-07 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |